As living in the midst of the COVID‚Äê19 pandemic becomes the new normal, the heterogeneity in the burden and secondary mortality across global epidemics has become increasingly evident. This is especially notable in Southeast Asia, a region with substantial variation in population density, income levels, access to healthcare, and public health infrastructure (Table). It has extensive travel exchanges with East Asia, but to date has experienced relatively limited local epidemics.